ZBH logo

ZIMMER BIOMET HOLDINGS INC

ZBHNYSE
πŸ† #480 by market capEarnings Nov 4US Equity
$446.73β–² $20.19 (+4.52%)
πŸŒ™ After hours$97.23β–Ό 78.24%Simulated price
1hβ€”
24hβ–² 4.5%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$18.37B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+8.6%
Slowing
πŸ“ŠGross Margin
69.9%
High
πŸ’΅FCF Margin
12.7%
Healthy
βš–οΈP/S Ratio
2.2x
Cheap
Otter Score
60
Fair
No chart data available for ZBH.

Trading Snapshot

Day Range
$441.63 – $455.48
52-Week Range
$79.12 – $108.29
Volume
$2.47B
Avg Volume
$3.06B
Shares Outstanding
193.5M
Next Earnings
Sep 20, 2026

Fundamentals Snapshot

Annual Revenue
$8.23B
Last Q Revenue
$2.18B
P/E Ratio
23.1
P/S Ratio
2.2x
EPS (TTM)
$4.11
Dividend Yield
1.01%

Why Investors Own ZBH

  • βœ“High-growth profile β€” revenue up -5.3% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 76% gross margin and 20% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$8.23Bβ–Ό βˆ’6.9% YoY
Gross Margin (TTM)
76.0%β–² +0.9% YoY
Operating Income (TTM)
$2.91Bβ–Ό βˆ’6.9% YoY
Free Cash Flow (TTM)
$1.62Bβ–Ό βˆ’6.9% YoY

About ZIMMER BIOMET HOLDINGS INC

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
60/100

Analyst Price Target

β“˜
Average Target
$445.06
β–Ό βˆ’0.4% Downside
High Target$517.18
Low Target$411.44
Based on 17 analysts

Latest News & Updates